Stay updated with breaking news from Secondary Progressive Multiple. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The software development company, Foogal, has just launched the Wahls Diet™ App, a program that removes the guesswork of searching for recipes...
/PRNewswire/ -- Author and leading medical expert in autoimmune disease, Dr. Terry Wahls, has joined forces with Foogal, a digital health software company, to...
Dr. David Zagzag is the Chief of the Division of Neuropathology at NYU Langone Health and a Professor of Pathology and Neurosurgery. Dr. Zagzag explains that there are more than 50 million American people affected by neurodegenerative diseases each year and below he explores the most common neurodegenerative diseases affecting the US today.
Nach Fingolimod, Siponimod und Ozanimod ist nun der vierte Sphingosin-1-Phosphat-Rezeptor-Modulator auf dem Markt. Ponesimod ist zugelassen bei Patienten m...
Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER Specialty Care sales grew 18.3%, driven by strong Dupixent performance (+54.2% to €982 million). Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. General Medicines declined 7.5%, reflecting lower U.S. Diabetes sales, COVID environment and portfolio streamlining. CHC down 3.0% due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands. Leveraged business EPS as the result of prioritization within R&D and...